Home › Funds › Haven Capital Group, Inc. › GILD
Haven Capital Group, Inc. position in GILD
GILEAD SCIENCES INC · Health Care
Haven Capital Group, Inc. reported holding 2,730 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$407K, representing 0.31% of its reported portfolio and ranking #32 among its reported holdings. Haven Capital Group, Inc. has disclosed GILD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Haven Capital Group, Inc.'s GILD position evolved
Haven Capital Group, Inc. first disclosed a stake in GILD in Q4 2024 at 4,625 shares (US$427K). The position peaked in Q1 2025 at 4,310 shares, worth US$483K. Across 8 filings, Haven Capital Group, Inc. increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 2,730 shares valued at US$407K. Notable position changes include a 32% trim in Q4 2025 (shares rose 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 4.62K | $427.21K | New |
| Q1 2025 | 4.31K | $483.00K | Reduce |
| Q2 2025 | 3.99K | $442.00K | Reduce |
| Q3 2025 | 3.99K | $443.00K | Hold |
| Q4 2025 | 2.73K | $335.00K | Reduce |
| Q1 2026 | 2.73K | $380.48K | Hold |
| Q2 2026 | 2.73K | $344.91K | Hold |
| Q3 2026 | 2.73K | $406.91K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 66.87M sh · $8.45B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Invesco Ltd 39.82M sh · $5.03B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
More on Haven Capital Group, Inc.
FAQ
How long has Haven Capital Group, Inc. held GILD?
Haven Capital Group, Inc. has disclosed GILD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Haven Capital Group, Inc.'s current position in GILD?
As of Q3 2026, Haven Capital Group, Inc. holds 2.73K shares of GILD (GILEAD SCIENCES INC), valued at $406.91K, representing 0.31% of its reported portfolio and ranking #32.
Has Haven Capital Group, Inc. been buying or selling GILD?
In the latest 13F filing (Q3 2026), Haven Capital Group, Inc. held unchanged its position in GILD. The position peaked in Q1 2025 at 4.31K shares.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.